World Health Organization

Summary

Organization: World Health Organization
Country: Switzerland

Top Publications

  1. doi Global mental health: the role of psychiatry
    Benedetto Saraceno
    Department of Mental Health and Substance Abuse, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland
    Eur Arch Psychiatry Clin Neurosci 259:S109-17. 2009
  2. ncbi The need and plan for global elimination of congenital syphilis
    George P Schmid
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    Sex Transm Dis 34:S5-10. 2007
  3. ncbi Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial
    Helena von Hertzen
    UNDP UNFPA WHO World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, WHO, Geneva, Switzerland
    Lancet 369:1938-46. 2007
  4. ncbi Sexually transmitted infections: key issues for clinical practice
    N Broutet
    Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
    Int J Gynaecol Obstet 97:229-31. 2007
  5. ncbi Epidemiology of periodontal status in dentate adults in France, 2002-2003
    D Bourgeois
    Global Oral Health Program, Department of Chronic Disease and Health Promotion, World Health Organization, Geneva, Switzerland
    J Periodontal Res 42:219-27. 2007
  6. ncbi Effects of maternal mortality on gross domestic product (GDP) in the WHO African region
    Joses M Kirigia
    Health Financing and Social Protection Unit, World Health Organization, Regional Office for Africa, Brazzaville, Congo
    Afr J Health Sci 13:86-95. 2006
  7. ncbi [WHO program for prequalification of antiretroviral, antimalarial and antituberculosis drugs]
    O Gross
    Organisation mondiale de la Sante, 20 Avenue Appia, CH 1211 Geneva 27, Suisse
    Med Trop (Mars) 66:549-51. 2006
  8. ncbi Art for women's health
    Mario Merialdi
    Reproductive Health and Research Department, World Health Organization, Geneva 1211, Switzerland
    Lancet 368:2113-4. 2006
  9. pmc The National Violent Death Reporting System: a new gold standard for the surveillance of violence related deaths?
    A Butchart
    Prevention of Violence, Department of Injuries and Violence Prevention, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Inj Prev 12:ii63-ii64. 2006
  10. pmc HIV in the Middle East
    Carla Makhlouf Obermeyer
    Department of HIV AIDS, World Health Organization, Geneva, 1211, Switzerland
    BMJ 333:851-4. 2006

Research Grants

  1. Testing and Counseling for HIV: A Multi-Site Study
    CARLA OBERMEYER; Fiscal Year: 2009
  2. Testing and Counseling for HIV: A Multi-Site Study
    CARLA OBERMEYER; Fiscal Year: 2007
  3. Testing and Counseling for HIV: A Multi-Site Study
    CARLA M OBERMEYER; Fiscal Year: 2010

Detail Information

Publications62

  1. doi Global mental health: the role of psychiatry
    Benedetto Saraceno
    Department of Mental Health and Substance Abuse, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland
    Eur Arch Psychiatry Clin Neurosci 259:S109-17. 2009
    ....
  2. ncbi The need and plan for global elimination of congenital syphilis
    George P Schmid
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    Sex Transm Dis 34:S5-10. 2007
    ..The newly proposed World Health Organization Strategy for the Global Elimination of Congenital Syphilis aims to mobilize resources and provide a plan ..
  3. ncbi Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial
    Helena von Hertzen
    UNDP UNFPA WHO World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, WHO, Geneva, Switzerland
    Lancet 369:1938-46. 2007
    ..Our aim was to assess the effects of the interval between multiple doses of misoprostol and the route of administration to terminate pregnancy...
  4. ncbi Sexually transmitted infections: key issues for clinical practice
    N Broutet
    Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
    Int J Gynaecol Obstet 97:229-31. 2007
  5. ncbi Epidemiology of periodontal status in dentate adults in France, 2002-2003
    D Bourgeois
    Global Oral Health Program, Department of Chronic Disease and Health Promotion, World Health Organization, Geneva, Switzerland
    J Periodontal Res 42:219-27. 2007
    ..The purpose of this study was to investigate the prevalence and the oral distribution of periodontal status among dentate adults in the general population of France...
  6. ncbi Effects of maternal mortality on gross domestic product (GDP) in the WHO African region
    Joses M Kirigia
    Health Financing and Social Protection Unit, World Health Organization, Regional Office for Africa, Brazzaville, Congo
    Afr J Health Sci 13:86-95. 2006
    ....
  7. ncbi [WHO program for prequalification of antiretroviral, antimalarial and antituberculosis drugs]
    O Gross
    Organisation mondiale de la Sante, 20 Avenue Appia, CH 1211 Geneva 27, Suisse
    Med Trop (Mars) 66:549-51. 2006
    ..Initially focusing on medicines for HIV/AIDS, TB and malaria, the Programme is now being expanded to also cover medicines for reproductive health...
  8. ncbi Art for women's health
    Mario Merialdi
    Reproductive Health and Research Department, World Health Organization, Geneva 1211, Switzerland
    Lancet 368:2113-4. 2006
  9. pmc The National Violent Death Reporting System: a new gold standard for the surveillance of violence related deaths?
    A Butchart
    Prevention of Violence, Department of Injuries and Violence Prevention, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Inj Prev 12:ii63-ii64. 2006
  10. pmc HIV in the Middle East
    Carla Makhlouf Obermeyer
    Department of HIV AIDS, World Health Organization, Geneva, 1211, Switzerland
    BMJ 333:851-4. 2006
  11. ncbi Prevalence of intimate partner violence: findings from the WHO multi-country study on women's health and domestic violence
    Claudia Garcia-Moreno
    WHO, Geneva, Switzerland
    Lancet 368:1260-9. 2006
    ....
  12. ncbi How much disease burden can be prevented by environmental interventions?
    Annette Prüss-Ustün
    Department of Public Health and the Environment, World Health Organization, Geneva, Switzerland
    Epidemiology 18:167-78. 2007
    ..The World Health Organization (WHO) recently completed a comprehensive, systematic, and transparent estimate of the disease burden ..
  13. ncbi Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update
    Sonia R Pagliusi
    Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    Vaccine 24:S3/193-200. 2006
    ..It is hoped that the establishment of International Units and International Standards for HPV antibody and DNA analysis will be pursued with high priority...
  14. ncbi Effectiveness of weekly iron-folic acid supplementation to prevent and control anemia among women of reproductive age in three Asian countries: development of the master protocol and implementation plan
    Tommaso Cavalli-Sforza
    WHO Regional Office for the Western Pacific, P O Box 2932, Manila, Philippines
    Nutr Rev 63:S77-80. 2005
    ..Each country utilized the same supplement but adapted implementation processes to their specific conditions. Social marketing and community mobilization were considered to be essential tools for sustainability...
  15. pmc International standard reagents for HPV detection
    Sonia R Pagliusi
    Department of Immunizations, Vaccines and Biologicals, World Health Organization, Av Appia 20, 1211 Geneva 27, Switzerland
    Dis Markers 23:283-96. 2007
    ..The advancement of prophylactic vaccine candidates against HPV infections and related diseases stresses the increasing importance of HPV assays in monitoring the impact of HPV vaccination on disease burden...
  16. ncbi Conclusions of the Joint WHO/UNICEF/IAEA/IZiNCG Interagency Meeting on Zinc Status Indicators
    Bruno de Benoist
    Department of Nutrition for Health and Development, World Health Organization, Geneva
    Food Nutr Bull 28:S480-4. 2007
    ..A working group meeting was convened by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF), the International Atomic Energy Agency (IAEA), and ..
  17. ncbi Endemic Japanese encephalitis in the Kathmandu valley, Nepal
    Jeffrey Partridge
    World Health Organization, Immunization Preventable Diseases Unit, Kathmandu, Nepal
    Am J Trop Med Hyg 77:1146-9. 2007
    ..Currently, JE prevention is focused on the Terai region in Nepal; given the evidence, this should be reviewed for the possible inclusion of the Kathmandu valley in the national JE prevention and control program...
  18. doi Role of hand hygiene in healthcare-associated infection prevention
    B Allegranzi
    First Global Patient Safety Challenge, World Alliance for Patient Safety, IER PSP, Room L319, L Building, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    J Hosp Infect 73:305-15. 2009
    ..The main objective of the First Global Patient Safety Challenge, launched by the World Health Organization (WHO), is to achieve an improvement in hand hygiene practices worldwide with the ultimate goal of ..
  19. doi Gender and HIV testing in Burkina Faso: an exploratory study
    Carla Makhlouf Obermeyer
    Department of HIV AIDS, World Health Organization, 20 Avenue Appia, 1211 Geneva, Switzerland
    Soc Sci Med 69:877-84. 2009
    ..The results are discussed in the context of Burkina Faso and in terms of their implications for efforts to improve access to services around HIV...
  20. doi Women are still deprived of access to lifesaving essential and emergency obstetric care
    Monir Islam
    Department of Making Pregnancy Safer, World Health Organization, 1121 Geneva 27, Switzerland
    Int J Gynaecol Obstet 106:120-4. 2009
    ....
  21. ncbi Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients
    Andrea Pantoja
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Int J Tuberc Lung Dis 13:698-704. 2009
    ..Bangalore City, India...
  22. ncbi Inclusion of information on risk factors, socio-economic status and health seeking in a tuberculosis prevalence survey
    K Lonnroth
    Stop Tuberculosis Department, World Health Organization, Geneva, Switzerland
    Int J Tuberc Lung Dis 13:171-6. 2009
    ..The article also discusses special considerations regarding sampling, sample size and data interpretation when including such information in a TB prevalence survey...
  23. doi Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India
    P Olliaro
    UNICEF UNDP WB WHO Special Programme for Research and Training in Tropical Diseases TDR, Geneva, Switzerland
    Trop Med Int Health 14:88-92. 2009
    ..To estimate drug costs of treating visceral leishmaniasis (VL) based on data on the VL population structure from the high-burden, antimony-resistant area of Northern Bihar, India...
  24. pmc Universal coverage of health services: tailoring its implementation
    Guy Carrin
    Department of Health Systems Financing, Health Systems and Services, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 86:857-63. 2008
    ..In this paper we propose a comprehensive framework focusing on health financing rules and organizations that can be used to support countries in developing their health financing systems in the search for universal coverage...
  25. doi Efficacy of monotherapies and artesunate-based combination therapies in children with uncomplicated malaria in Somalia
    Marian Warsame
    Division of International Health, Karolinska Institutet, Stockholm, Sweden
    Acta Trop 109:146-51. 2009
    ..A 28-day test of artemisinin-based combinations, AS+SP and AS+AQ, proved to be highly efficacious with cure rates of 98-100% supporting the choice of AS+SP combination as first line treatment for uncomplicated malaria for Somalia...
  26. doi Global epidemiology of tuberculosis: prospects for control
    Knut Lonnroth
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Semin Respir Crit Care Med 29:481-91. 2008
    ..Implementation of the World Health Organization's Stop TB Strategy is currently lagging behind the envisioned scale-up pace, particularly with regard to ..
  27. ncbi World Health Organization global policy for improvement of oral health--World Health Assembly 2007
    Poul Erik Petersen
    World Health Organization, Global Oral Health Programme, Department of Chronic Disease and Health Promotion, Geneva, Switzerland
    Int Dent J 58:115-21. 2008
    The World Health Organization (WHO) Global Oral Health Programme has worked hard over the past five years to increase the awareness of oral health worldwide as an important component of general health and quality of life...
  28. ncbi [Health impact of ozone in 13 Italian cities]
    Francesco Mitis
    World Health Organization, European Centre for Environment and Health, Roma
    Epidemiol Prev 31:323-32. 2007
    ..to estimate the health impact of ozone in 13 Italian cities over 200,000 inhabitants and to produce basic elements to permit the reproducibility of the study in other urban locations...
  29. doi Human resources for global health: time for action is now
    Francis Omaswa
    Global Health Workforce Alliance, WHO, CH 1211 Geneva 27, Switzerland
    Lancet 371:625-6. 2008
  30. doi Health and urban living
    Christopher Dye
    World Health Organization, 1211 Geneva 27, Switzerland
    Science 319:766-9. 2008
    ..Subject to better evidence, I suggest that the main obstacles to improving urban health are not technical or even financial, but rather are related to governance and the organization of civil society...
  31. ncbi Drug resistance hampers our capacity to roll back malaria
    Piero Olliaro
    United Nations International Children s Emergency Fund United Nations Development Programme World Bank World Health Organization Special Programme on Research and Training in Tropical Diseases, Geneva, Switzerland
    Clin Infect Dis 41:S247-57. 2005
    ..The current situation favors the development of sensible strategies to restrain resistance...
  32. ncbi Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand
    J Hombach
    Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
    Vaccine 23:2689-95. 2005
    ..This event, co-sponsored by the World Health Organization (WHO) and the Thai Ministry of Public Health, reviewed the progress made with vaccine development, sero-..
  33. ncbi Leishmania/HIV co-infections: epidemiology in Europe
    P Desjeux
    Strategy Development and Monitoring of Zoonoses, Foodborne Diseases and Kinetoplastidae, Department of Control, Prevention and Eradication ZFK CPE, World Health Organization, 20 Avenue Appia, CH 1211 Geneva 27, Switzerland
    Ann Trop Med Parasitol 97:3-15. 2003
    ..of surveillance for the co-infection, which now includes 28 member institutions, was established by the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS)...
  34. ncbi Longitudinal growth patterns of Pakistani infants in a clinic based growth promotion program
    Shamim A Qazi
    Children Hospital, Pakistan Institute of Medical Sciences, G 8 3, Islamabad, Pakistan
    Indian Pediatr 40:1043-53. 2003
    ..To describe the operation of growth monitoring and promotion (GMP) clinic and longitudinal growth patterns of children...
  35. ncbi Dietary diversity, child nutrition and health in contemporary African communities
    Adelheid W Onyango
    Department of Nutrition for Health and Development, World Health Organization, 20 Avenue Appia, CH 1211 27, Geneva, Switzerland
    Comp Biochem Physiol A Mol Integr Physiol 136:61-9. 2003
    ..Dietary diversity is proposed as a candidate indicator of food security and predictor of nutritional status, but there is need for further research to standardize definitions and methodology before it can be applied widely...
  36. ncbi Quality of care and the demand for health services in Bamako, Mali: the specific roles of structural, process, and outcome components
    Mamadou Mariko
    Essential Drugs and Medicines Department, World Health Organization, 20, Avenue Appia, CH 1211 27, Geneva, Switzerland
    Soc Sci Med 56:1183-96. 2003
    ....
  37. pmc Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000
    Kenji Shibuya
    Global Program on Evidence for Health Policy, World Health Organization, Geneva, Switzerland
    BMC Cancer 2:37. 2002
    ..We present the detailed estimates of mortality and incidence by site as the basis for the future estimation of cancer burden for the Global Burden of Disease 2000 study...
  38. ncbi Current problems of drug-resistant tuberculosis and its control
    Sang Jae Kim
    Tuberculosis Strategy and Operations, Stop TB Department, World Health Organization, 20 Avenue Appia, CH 1211 Geneva, Switzerland
    Kekkaku 77:735-40. 2002
    ..We must therefore exert our best efforts to prevent the further generation of such cases by improving the cure rate of newly diagnosed cases, and by aggressively intervening to identify and remove MDR-TB cases as soon as possible...
  39. ncbi [First major epidemic caused by Neisseria meningitidis serogroup W135 in Africa?]
    E Bertherat
    Global Alert and Response, CSR CDS, 20 Avenue Appia, CH 1211 Genève 27, Suisse
    Med Trop (Mars) 62:301-4. 2002
    ..Control strategy for epidemic meningitis is currently the focus of close collaboration between the WHO and the health authorities and corresponding institutions in the countries involved...
  40. pmc Will tuberculosis become resistant to all antibiotics?
    C Dye
    Communicable Diseases, World Health Organization, Geneva, Switzerland
    Proc Biol Sci 268:45-52. 2001
    ..To substantiate this result, further measurements are needed of the relative fitness of drug-resistant strains...
  41. pmc Estimating the burden of disease from water, sanitation, and hygiene at a global level
    Annette Prüss
    World Health Organization, Protection of the Human Environment, Geneva, Switzerland
    Environ Health Perspect 110:537-42. 2002
    ..This significant and avoidable burden suggests that it should be a priority for public health policy...
  42. ncbi Invited commentary: pertussis, a forgotten killer
    Philippe Duclos
    Department of Vaccines and Biologicals, Health Technology and Pharmaceuticals, World Health Organization, 20 Avenue Appia, CH 1211 Geneva 27, Switzerland
    Am J Epidemiol 155:897-8. 2002
  43. ncbi Dilemmas and opportunities for an appropriate health-service response to violence against women
    C Garcia-Moreno
    Department of Gender and Women s Health, WHO, 20 Avenue Appia, Geneva 1211, Switzerland
    Lancet 359:1509-14. 2002
    ....
  44. ncbi Hot spots in a wired world: WHO surveillance of emerging and re-emerging infectious diseases
    D L Heymann
    World Health Organization, Communicable Disease Programmes, Geneva, Switzerland
    Lancet Infect Dis 1:345-53. 2001
    ..About 65% of the world's first news about infectious disease events now comes from informal sources, including press reports and the internet...
  45. ncbi Development and validation of a 'tablet pole' for the administration of praziquantel in sub-Saharan Africa
    A Montresor
    World Health Organization, Diseases Control, Prevention and Eradication, Parasitic Diseases and Vector Control, Avenue Appia 20, CH 1211 Geneva 27, Switzerland
    Trans R Soc Trop Med Hyg 95:542-4. 2001
    ..In more than 98% of the cases the indicated dose was within the range that has proven efficacious and safe (30 and 60 mg/kg)...
  46. ncbi The joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications
    Chizuru Nishida
    Department of Nutrition for Health and Development, WHO, Geneva, Switzerland
    Public Health Nutr 7:245-50. 2004
  47. pmc Kenneth Arrow and the birth of health economics
    William D Savedoff
    World Health Organization, Geneva, Switzerland
    Bull World Health Organ 82:139-40. 2004
  48. ncbi Medication use, gender, and socio-economic status in Lebanon: analysis of a national survey
    Carla Makhlouf Obermeyer
    Department of Gender and Women s Health, World Health Organization, Geneva, Switerland
    J Med Liban 50:216-25. 2002
    ....
  49. ncbi Strategies for effective and sustainable national nutrition plans and policies
    Chizuru Nishida
    World Health Organization, Department of Nutrition for Health and Development, Sustainable Development and Healthy Environments, Geneva, Switzerland
    Forum Nutr 56:264-6. 2003
  50. pmc Rebuilding the ship as we sail: knowledge management in antiretroviral treatment scale-up
    Christopher Bailey
    Department of Knowledge Management and Sharing, Evidence and Information for Policy, World Health Organization, 1211 Geneva 27, Switzerland
    Bull World Health Organ 82:798-800. 2004
  51. ncbi [Rofecoxib (Vioxx) has been withdrawn, what next?]
    Juhana E Idänpään-Heikkilä
    Lääketieteen tiedejärjestöjen kansainvälinen neuvosto CIOMS, c o World Health Organization, Geneva, Switzerland
    Duodecim 120:2489-90. 2004
  52. pmc Is the "3 by 5" initiative the best approach to tackling the HIV pandemic?
    Jim Yong Kim
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    PLoS Med 1:e37. 2004
    The World Health Organization (WHO) and its partners aim to treat 3 million people infected with HIV in poor and middle income countries with antiretroviral treatment by the end of 2005...
  53. ncbi Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding
    Catherine d'Arcangues
    Special Programme of Research, World Health Organization, Development and Research Training in Human Reproduction HRP, CH 1211 Geneva 27, Switzerland
    Contraception 70:451-62. 2004
    ....
  54. ncbi The significance of the Cancun (non)outcome for the health sector
    Alaka Singh
    World Health Organisation, Health and Development Policy, 20 Avenue Appia, Geneva 1211, Switzerland
    Health Policy 70:255-6. 2004
  55. ncbi Overcoming health-systems constraints to achieve the Millennium Development Goals
    Phyllida Travis
    Department of Health System Policies, WHO, Geneva, Switzerland
    Lancet 364:900-6. 2004
    ..The forthcoming Ministerial Summit on Health Research seeks to help define a learning agenda for health systems, so that by 2015, substantial progress will have been made to reducing the system constraints to achieving the MDGs...
  56. ncbi HIV drug resistance surveillance: summary of an April 2003 WHO consultation
    Stefano Lazzari
    World Health Organization, Geneva, Switzerland
    AIDS 18:S49-53. 2004
    ..Although relevant progress has been made, several important challenges still exist to the implementation of this essential and innovative programme...
  57. ncbi The WHO/FIGO Alliance for Women's Health
    T Turmen
    Community and Family Health, World Health Organization, Avenue Appia 20, Geneva, Switzerland
    Int J Gynaecol Obstet 86:323-7. 2004
  58. pmc World health system performance revisited: the impact of varying the relative importance of health system goals
    Jeremy A Lauer
    Evidence and Information for Policy, World Health Organization, Geneva, Switzerland
    BMC Health Serv Res 4:19. 2004
    In 2002, the World Health Organization published a health system performance ranking for 191 member countries. The ranking was based on five indicators, with fixed weights common to all countries.
  59. ncbi Health information for all by 2015?
    Christopher Bailey
    World Health Organization, CH 1211 Geneva 27, Switzerland
    Lancet 364:223-4. 2004
  60. ncbi Dangerous pathogens in the laboratory: from smallpox to today's SARS setbacks and tomorrow's polio-free world
    David L Heymann
    Polio Eradication InitiativeWHO, Geneva 1211, Switzerland
    Lancet 363:1566-8. 2004
  61. ncbi What's in a policy context?
    Miguel A Gonzalez-Block
    Alliance for Health Policy and Systems Research, Office No 3148, World Health Organization, Geneva, Switzerland
    J Public Health Policy 25:56-7. 2004
  62. pmc The epidemiology of human immunodeficiency virus in South Africa
    B G Williams
    World Health Organization, 20 Avenue Appia, Geneva 27, CH 1211, Switzerland
    Philos Trans R Soc Lond B Biol Sci 356:1077-86. 2001
    ..We conclude by discussing some of the research that is needed and steps that could be taken to reduce the continued spread of the infection...

Research Grants14

  1. Testing and Counseling for HIV: A Multi-Site Study
    CARLA OBERMEYER; Fiscal Year: 2009
    ..Analyses will combine statistical methods for quantifiable survey data, and qualitative methods for the textual data resulting from open-ended responses and observations. ..
  2. Testing and Counseling for HIV: A Multi-Site Study
    CARLA OBERMEYER; Fiscal Year: 2007
    ..Analyses will combine statistical methods for quantifiable survey data, and qualitative methods for the textual data resulting from open-ended responses and observations. ..
  3. Testing and Counseling for HIV: A Multi-Site Study
    CARLA M OBERMEYER; Fiscal Year: 2010
    ..Analyses will combine statistical methods for quantifiable survey data, and qualitative methods for the textual data resulting from open-ended responses and observations. ..